Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to LenalidomideBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 1 / Phase 22026-05-11NCT05060627

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Adknoma Health Research3
PETHEMA Foundation21

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Clínica Universidad de Navarra (CUN)PamplonaSpain2
Complejo Hospitalario Santiago (CHUS)Santiago de CompostelaSpain3
Complejo Hospitalario Virgen del RocíoSevilleSpain1
H. Gregorio MarañónMadridSpain2
H. Morales MeseguerMurciaSpain3
H. Son LlatzerPalma de MallorcaSpain1
H. Universitario de CanariasSanta Cruz de TenerifeSpain1
H. Universitario Marqués de ValdecillaSantanderSpain4
H.U. La FeValenciaSpain2
Hospital ClinicBarcelonaSpain13
Hospital Germans Trias i Pujol (ICO BADALONA)BadalonaSpain3
Hospital Universitario 12 De OctubreMadridSpain98
Hospital Universitario de SalamancaSalamancaSpain29
HUCAOviedoSpain2
ICO Duran i ReynalsL'Hospitalet de LlobregatSpain1